PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-10-05

Date Title Company
05-Oct-2022 Orangewood Partners Makes Strategic Investment in Barrington James Businesswire
05-Oct-2022 Thermo Fisher Scientific Introduces Decentralized Clinical Trials Network Businesswire
05-Oct-2022 Palleon Co-Founder Dr. Carolyn Bertozzi Awarded Nobel Prize in Chemistry for Pioneering Methods of Studying Glycobiology Businesswire
05-Oct-2022 2BScientific moves to an Eco-friendly and Sustainable Future at Kirtlington Business Park 2b Scientific
05-Oct-2022 New Data From Repertoire® Immune Medicines Demonstrate Effectiveness of Its DECODE™ Platform to Characterize and Identify New Immunotherapeutic Targets in HPV Positive Cancer Businesswire
05-Oct-2022 U.S. Food and Drug Administration Accepts Takeda’s Supplemental Biologics License Application for Use of TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older Businesswire
05-Oct-2022 Resource Label Group Acquires Chicago based Deco Flexible Packaging Businesswire
05-Oct-2022 Apnimed Expands Senior Leadership Team by Appointing John Cronin, M.D., Senior Vice President, Clinical Development Businesswire
05-Oct-2022 AbCellera Announces Presentation of Data from CD3 T-Cell Engager Platform at SITC 2022 Businesswire
05-Oct-2022 Adicet Bio to Present Preclinical Data from Allogeneic Gamma Delta T Cell Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting Businesswire
05-Oct-2022 Asher Bio to Present New Preclinical Data for CD8+ T Cell Targeted Immunotherapies, AB248 and AB821, at SITC 2022 Businesswire
05-Oct-2022 Clarametyx Announces FDA Acceptance of Investigational New Drug (IND) Application for Phase 1 Study of Immune-Enabling Antibody Therapy CMTX-101 Businesswire
05-Oct-2022 IconOVir Bio to Present Preclinical Data on Lead Candidate ICVB-1042 at SITC 2022 Businesswire
05-Oct-2022 Alzamend Neuro Announces Addition of Healthy Subjects to Ongoing Phase IIA Clinical Trial for AL001 in Alzheimer’s Subjects Businesswire
05-Oct-2022 Thermo Fisher Scientific Announces New Cryo-TEM with Expansive Automation Features to Help Accelerate Drug Discovery Research Businesswire
05-Oct-2022 Catamaran Bio to Present Preclinical Efficacy Data for Allogeneic CAR‑NK Cell Therapies to Treat Solid Tumors at SITC Annual Meeting Businesswire
05-Oct-2022 Areteia Therapeutics announces the appointments of Dr. Eric Bradford as Chief Medical Officer, and Robin Walker as Chief Legal Officer and Corporate Secretary Businesswire
05-Oct-2022 KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium Businesswire
05-Oct-2022 Insights on the High-Throughput Screening Global Market to 2027 - Government Funding and Venture Capital Investments Present Opportunities - ResearchAndMarkets.com Businesswire
05-Oct-2022 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire